首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
【2h】

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction

机译:在引入PCV之后的五个冬季中英国运输中出现了肺炎球菌血清型替换

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The seven-valent pneumococcal conjugate vaccine (PCV7) was added to the UK national immunisation programme in September 2006. PCV13 replaced PCV7 in April 2010. As carriage precedes disease cases this study collected carried pneumococci from children each winter from 2006/7 to 2010/11 over PCV introduction. Conventional microbiology and whole genome sequencing were utilised to characterise pneumococcal strains.Overall prevalence of pneumococcal carriage remained stable. Vaccine serotypes (VT) decreased (p < 0.0001) with concomitant increases in non-vaccine serotypes (NVT). In winter 2010/11 only one isolate of PCV7 VT was observed (6B). PCV13 unique VTs decreased between winters immediately preceding and following PCV13 introduction (p = 0.04). Significant decreases for VTs 6B, 19F, 23F (PCV7) and 6A (PCV13) and increases for NVT 21, 23B, 33F and 35F were detected. The serotype replacement was accompanied by parallel changes in genotype prevalence for associated sequence types with clonal expansion contributing to replacement. By winter 2010/11, serotype coverage of PCV7 and PCV13 was 1% and 11% respectively.VT replacement was observed for PCV7 and PCV13 serotypes. Conjugate vaccine design and use requires continuous monitoring and revision.
机译:2006年9月,七价肺炎球菌结合疫苗(PCV7)被添加到英国国家免疫计划中。2010年4月,PCV13取代了PCV7。由于在疾病病例携带之前,该研究从2006/7到2010/7的每个冬天都从儿童身上携带肺炎球菌。 11在PCV上的介绍。常规微生物学和全基因组测序被用于表征肺炎球菌菌株。总体肺炎球菌携带率保持稳定。疫苗血清型(VT)下降(p <0.0001),同时非疫苗血清型(NVT)增加。在2010/11年冬季,仅观察到一株PCV7 VT分离株(6B)。在引入PCV13之前和之后的冬天之间,PCV13的唯一VT降低(p = 0.04)。检测到VT 6B,19F,23F(PCV7)和6A(PCV13)显着降低,NVT 21、23B,33F和35F显着降低。血清型替换伴随着相关序列类型的基因型流行率的平行变化,而克隆扩展则导致替换。到2010/11年冬季,PCV7和PCV13的血清型覆盖率分别为1%和11%。观察到PCV7和PCV13血清型的VT替代。结合疫苗的设计和使用需要不断的监测和修订。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号